Development of rapid detection tests for Brucella species

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$607,822.00
Award Year:
2006
Program:
SBIR
Phase:
Phase I
Contract:
1R43AI068166-01A1
Award Id:
79732
Agency Tracking Number:
AI068166
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
562 1ST AVE. SOUTH, SUITE 600, SEATTLE, WA, 98104
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
WILLIAM MORROW
(206) 344-5821
wjwmorrow@inbios.com
Business Contact:
(206) 344-5821
Research Institute:
n/a
Abstract
DESCRIPTION (provided by applicant): Brucellosis is a re-emerging zoonotic disease that affects humans and a variety of farm animals. As well as a threat to public health it has considerable economic importance. The etiologic agent responsible for human infection, Brucella melitensis, is classified by both NIAID and CDC as a Category B biothreat pathogen. Antibiotics are only partially effective at controlling the disease and there is no vaccine approved for use in humans. Thus prompt and accurate diagnosis is the key to containing infection. Currently the most common diagnostic tests for Brucella are based on indirect serology which are lacking in specificity and sensitivity as well as speed of execution. Thus there is a pressing need to develop improved diagnostics, especially technologies that may be used at field level. This investigation proposes to address this issue and develop a superior and robust technique for diagnosing Brucella infection with highly specific, non- cross reactive antibody reactions. We will achieve this goal by screening the Brucella genome using novel proteomic chip technology to identify unique antigens that will yield highly specific and accurate diagnoses. This work will be undertaken in Phase 1 of the application. In Phase 2, when antigens have been selected, we anticipate that we will proceed to develop ELISA and immunoblot assays. In parallel both ELISA and lateral flow "dipstick" tests for Brucella antigen will be constructed. We envisage that the antigen assays will have particular utility in detecting Brucella disseminated in the context of the bioterrorism event. The diagnostic tools developed within this application will be rigorously evaluated for sensitivity and specificity using large and diverse panels of human and animal Brucella-positive sera available through our collaborators. The project proposes to develop a highly sensitive and robust diagnostic test for brucellosis, also known as "undulant fever", an infectious disease that causes serious illness in farm animals and humans. The current techniques for diagnosing infection are somewhat unreliable and based on outmoded methods. This investigation will use state- of-the-art technology to identify new structures or antigens on Brucella bacteria that may be used to develop a test with superior diagnostic performance.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government